Blood‐based biomarkers for Alzheimer's disease-Reference-Cited by-同舟云学术

Blood‐based biomarkers for Alzheimer's disease

Published:2021-12-03 Issue:1 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Leuzy Antoine¹^ORCID,Mattsson‐Carlgren Niklas¹²³^ORCID,Palmqvist Sebastian¹⁴^ORCID,Janelidze Shorena¹^ORCID,Dage Jeffrey L⁵^ORCID,Hansson Oskar¹⁴^ORCID

Affiliation:

1. Clinical Memory Research Unit Department of Clinical Sciences Lund University Malmö Sweden

2. Department of Neurology Skåne University Hospital Lund Sweden

3. Wallenberg Centre for Molecular Medicine Lund University Lund Sweden

4. Memory Clinic Skåne University Hospital Lund Sweden

5. Stark Neuroscience Research Institute Indiana University School of Medicine Indianapolis IN USA

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202114408

Reference157 articles.

1. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's disease;1997;Neurobiol Aging

2. Promising results in 18‐month analysis of Alzheimer drug candidate;Abbasi J;JAMA,2018

3. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia

4. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5. Targeting Neuroinflammation to Treat Alzheimer’s Disease

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA;Neurobiology of Aging;2024-11

2. Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier;Ageing Research Reviews;2024-11

3. A streamlined, resource-efficient immunoprecipitation-mass spectrometry method for quantifying plasma amyloid-β biomarkers in Alzheimer's disease;2024-09-02

4. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice;Alzheimer's & Dementia;2024-08-03

5. Clinical utility of diffusion MRI‐derived measures of cortical microstructure in a real‐world memory clinic setting;Annals of Clinical and Translational Neurology;2024-07-24